{u'keywords': [u'Mr Stokoe', u'evidence', u'Gambro', u'opinion', u'Gambro Australia', u'Evidence Act', u'expert evidence', u'court', u'Gambro Group', u'Gambro Renal Products', u'technical sales representative', u'Gambro Industries SAS', u'Red Bull', u'New South Wales', u'market', u'expert opinion', u'knowledge', u'relevant specialised knowledge', u'expert opinion evidence', u'Gambro HD Machines', u'Heydon JA', u'Federal Court', u'hd products', u'Gambro Healthcare divisions', u'Gambro Lundia AB', u'Additional HD Products', u'case', u'Gambro Pty', u'Gambro AB', u'marketing manager', u'new HD products', u'admissible evidence', u'Interim Evidence Report', u'Fresenius Medical Care', u'Care Australia Pty', u'Medical Care Australia', u'HD treatments', u'Australian market', u'hospital staff', u'technical sales representatives', u'provisionally admitted evidence', u'relevant evidence', u'Bull Australia Pty', u'earlier oral evidence', u'Gambro machine', u'Red Bull Australia', u'haemodialysis market', u'question', u'sales amp', u'dry bicarbonate'], u'casename': u'Gambro Pty Ltd v Fresenius Medical Care Australia Pty Ltd [2007] FCA 1828 (21 November 2007)', u'filename': u'training_data/07_1828.xml'}